Masanosuke Ono announced his commitment to Penn State two days after the Nittany Lions won their fourth straight NCAA wrestling title. Masanosuke Ono signs autographs after the “FloWrestling ...

Curator, Christophe Cherix: In Cut Piece, members of the audience were invited to approach and cut away pieces of Ono’s clothing, as she knelt silently on a stage. Yoko Ono: When I do the Cut Piece, I ...

Japanese star Masanosuke Ono has enrolled in the university and is now officially listed in the student directory. Ono, 21, has recently been training with the Nittany Lion Wrestling Club and Penn ...

John Lennon and Yoko Ono's message and legacy is being carried forward by their son Sean Ono Lennon, a musician, producer and artist. The younger Lennon, who also has a half brother through his ...

Penn State’s wrestling dynasty might be adding a world champion to its roster. Japanese star Masanosuke Ono, a 2024 world champion, is now officially listed in Penn State’s student directory.

Getty(2) A new documentary about John Lennon and Yoko Ono is especially meaningful Sean Ono Lennon. In an interview with MOJO Magazine on Wednesday, March 19, the Plastic Ono Band artist opened up ...

Featuring the work of Japanese-born American artist Yoko Ono, it was scheduled to open in London the next day. Spying a stand with a note saying “Apple,” Lennon took a bite. When he realized ...

"My response, and the board's response, to this whole to divest, or cut those relationships, was to actually invest even more," Ono said. "The three of us have put more money into it, and great ...

The artist and singer said she "upgraded" her social standing once she met her musician husband in the trailer for upcoming documentary 'One to One' Courtesy of Magnolia Pictures Yoko Ono knows ...

Japan's Ono Pharmaceutical is handing over $280 million upfront to acquire Ionis Pharmaceuticals’ phase 2-stage antisense oligonucleotide for a rare type of blood cancer. The RNA-targeted ...

Image credit: Shutterstock/ Suan Taang. Japan-based Ono Pharmaceuticals has secured the global rights to sapablursen, an RNA-targeting therapy developed by Ionis Pharmaceuticals for the treatment of ...

Ionis will receive $280 million upfront and could get up to $660 million in future milestone payments. Ono will take charge of late-stage development as well as regulatory and commercialization ...